Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease

BMC Cardiovascular Disorders

Volumn 5, Issue , 2005, Pages

  Rothenbacher, Dietrich ^a   Brenner, Hermann ^a   Mertens, Thomas ^b   Hoffmann, Michael M ^c   Hoffmeister, Albrecht ^d   Koenig, Wolfgang ^d  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; IL1RN PROTEIN, HUMAN; SIALOGLYCOPROTEIN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; BLOOD; CYTOMEGALOVIRUS INFECTION; GENETICS; HOMOZYGOTE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEROLOGY;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; SIALOGLYCOPROTEINS;

EID: 26844451404     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-5-10     Document Type: Article

References (17)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 34:115-126.
2. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Ciculation 1999, 100:e20-28.
3. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996, 335:624-630.
4. Sweet C: The pathogenicity of cytomegalovirus. FEMS Microbiol Rev 1999, 23:457-482.
5. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34:204-209.
6. Rothenbacher D, Hoffmeister A, Bode G, Wanner P, Koenig W, Brenner H: Cytomegalovirus infection and coronary heart disease: results of a case-control study from Germany. J Infect Dis 1999, 179:690-692.
7. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999, 99:861-866.
8. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350:430-436.
9. Danesh J: Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: metaanalyses of prospective studies. Am Heart J 1999, 138:S434-S437.
10. Ridker PM, Hennekens CH, Stampfer MJ, Wang F: Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998, 98:2796-99.
11. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999, 100:e20-28.
12. O'Connor S, Taylor C, Campbell LA, Epstein S, Libby P: Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001, 7:780-788.
13. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, von Beckerath N, Bottiger C, Duff GW, Schomig A: Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000, 36:2168-2173.
14. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE: Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999, 34:1738-1743.
15. Muhlestein JB, Horne BD, Carlquist JF, Csako G, Epstein SE: Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000, 102:1917-1923.
16. Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G, Hafner G, Ossendorf M, Steinhagen K, Meyer J: Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 2001, 103:2915-2921.
17. Rothenbacher D, Hoffmeister A, Brenner H, Mertens T, Persson K, Koenig W: Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease. Role of confounding and reference group. Atherosclerosis 2003, 170:339-345.